Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference
Go back to Fulcrum Therapeutics Presents Data for Potential FSHD Biomarker and Clinical Outcome Assessments at 2021 Muscular Dystrophy Association (MDA) Virtual Clinical & Scientific Conference(NASDAQ: FULC) | Delayed: 7.10 -0.18 (2.47%) | |||||
---|---|---|---|---|---|---|
Previous Close | $7.28 | 52 Week High | $ | |||
Open | $7.07 | 52 Week Low | $ | |||
Day High | $7.18 | P/E | N/A | |||
Day Low | $6.85 | EPS | $ | |||
Volume | 164,754 |